Facial erysipelas in the immunocompromised host. Report of two cases.
Two cases of facial erysipelas in immunologically altered hosts are reported herein. The unusual presentation with absence of erythema in the skin lesion is emphasized. Atypical fever patterns were also noted. In one patient, the facial lesion followed the onset of fever by 48 hours, and, in the other, the facial swelling preceded the fever. Various aspects of the patient's altered host status are discussed in light of the atypical clinical presentation. Recognition of facial erysipelas as a potential source of group A beta-hemolytic streptococcemia in immune-altered hosts is important to ensure rapid and appropriate therapeutic intervention.
D000328:Adult; D004802:Eosinophilia / Q000188:drug therapy; D004886:Erysipelas / Q000209:etiology*; D005145:Face; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male